These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 13623976)

  • 1. Detecting poliovirus in vaccine lots used in Idaho in 1955.
    EKLUND CM; HADLOW WJ; PICKENS EG; GERLOFF RK
    Public Health Rep (1896); 1959 Jan; 74(1):60-6. PubMed ID: 13623976
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization with live attenuated poliovirus vaccine.
    KRUGMAN S; WARREN J; EIGER MS; BERMAN PH; MICHAELS RM; SABIN AB
    Am J Dis Child; 1961 Jan; 101():23-9. PubMed ID: 13754588
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination with Koprowski's live attenuated polio vaccine in the area of Gdansk and Olsztyn provinces. II. Results of viral examinations of persons vaccinated with live, attenuated poliovirus vaccine.
    GEORGIADES J; MORZYCKA M; MAKAREWICZ J; RODKIEWICZ T
    Biul Inst Med Morsk Gdansk; 1961; 12():29-36. PubMed ID: 13897793
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of live attenuated poliovirus vaccine in healthy infants].
    OKAZIMA S
    Virus; 1961 Oct; 11():317-32. PubMed ID: 14481544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the oral administration of live attenuated poliovirus vaccine in the monkey].
    KAMBARA Y
    Virus; 1961 Oct; 11():333-49. PubMed ID: 14453401
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of Cuban children to oral vaccination with living attenuated poliovirus vaccines. A clinical and serological study.
    EMBIL J
    Br Med J; 1960 Apr; 1(5180):1157-62. PubMed ID: 13820150
    [No Abstract]   [Full Text] [Related]  

  • 7. THE REDUCTION OF WILD POLIOVIRUS CIRCULATION FOLLOWING VACCINATION WITH THE LIVE VACCINE. A NEW FACTOR IN THE OECOLOGY OF ENTERIC VIRUSES?
    PESEK J; VOBECKY J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():262-3. PubMed ID: 14184882
    [No Abstract]   [Full Text] [Related]  

  • 8. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus.
    VAN HOOSIER GL; BARON S; KIRSCHSTEIN RL; ABINANTI FR
    Am J Hyg; 1962 Jan; 75():86-9. PubMed ID: 13924586
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliomyelitis vaccination with live poliovirus.
    BUSER F; SCHAR M
    Am J Dis Child; 1961 May; 101():568-74. PubMed ID: 13689341
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of live attenuated poliovirus vaccine.
    SKINNER RG
    J Fla Med Assoc; 1960 May; 46():1387-9. PubMed ID: 13831482
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and inactivation of purified poliovirus: comparison of vaccines derived from Mahoney and Parker poliovirus.
    CHARNEY J; FISHER WP; MACHLOWITZ RA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):601-5. PubMed ID: 13505802
    [No Abstract]   [Full Text] [Related]  

  • 15. Properties and behavior of orally administered attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1957 Jul; 164(11):1216-23. PubMed ID: 13438685
    [No Abstract]   [Full Text] [Related]  

  • 16. Status of field trials with an orally administered, live attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1959 Oct; 171():863-8. PubMed ID: 14440556
    [No Abstract]   [Full Text] [Related]  

  • 17. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine.
    JUNGHERR EL; CABASSO VJ; MOYER AW; COX HR
    J Infect Dis; 1961; 108():247-61. PubMed ID: 13791071
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent results of mass immunization against poliomyelitis with Koprowski strains of attenuated live poliovirus.
    PLOTKIN SA
    Am J Public Health Nations Health; 1962 Jun; 52(6):946-60. PubMed ID: 14487227
    [No Abstract]   [Full Text] [Related]  

  • 19. Interference patterns encountered when using attenuated poliovirus vaccines.
    HALE JH; LEE LH; GARDNER PS
    Br Med J; 1961 Sep; 2(5254):728-32. PubMed ID: 13710702
    [No Abstract]   [Full Text] [Related]  

  • 20. Communitywide vaccination program with attenuated poliovirus in Andes, Colombia.
    ABAD-GOMEZ H; PIEDRAHITA F; SOLORZANO R; MARTINS DA SILVA M
    J Am Med Assoc; 1959 Jun; 170(8):906-13. PubMed ID: 13654038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.